CB

Christopher S. Boerner

Chief executive, Bristol Myers Squibb

Christopher S. Boerner is a chief executive at Bristol Myers Squibb. They also file at Colgate-Palmolive (director). Their most recent Section 16 filing is from March 2026.

Known for
chief executive at Bristol Myers Squibb

Sign up

Get your curated digest

After email confirmation, you will receive a daily digest of the most relevant news that matter to your portfolio